华康医疗
(301235)
| 流通市值：9.80亿 | | | 总市值：20.31亿 |
| 流通股本：5095.20万 | | | 总股本：1.06亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 206,540,180.12 | 267,939,052.33 | 317,978,296.66 | 374,970,380.57 |
| 应收票据及应收账款 | 1,339,400,343.34 | 1,395,330,568.4 | 1,296,929,834.69 | 1,232,151,250.13 |
| 其中：应收票据 | 27,725,643.88 | 23,710,559.31 | 2,273,005.24 | 3,750 |
| 应收账款 | 1,311,674,699.46 | 1,371,620,009.09 | 1,294,656,829.45 | 1,232,147,500.13 |
| 应收款项融资 | - | 772,224.69 | 2,669,626.34 | - |
| 预付款项 | 22,895,253.57 | 18,347,140.57 | 50,719,716.35 | 57,777,924.3 |
| 其他应收款合计 | 22,761,854.42 | 15,637,802.93 | 20,239,889.93 | 17,569,657.9 |
| 存货 | 286,941,781.54 | 274,909,613.7 | 296,531,395.76 | 326,977,018.57 |
| 合同资产 | 94,776,599.78 | 73,184,017.84 | 84,760,219.46 | 77,042,331.55 |
| 其他流动资产 | 36,262,707.55 | 68,103,979.66 | 27,218,844.9 | 14,735,157.08 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,009,578,720.32 | 2,114,224,400.12 | 2,097,047,824.09 | 2,101,223,720.1 |
| 非流动资产: | | | | |
| 其他权益工具投资 | - | - | 10,000,000 | 10,000,000 |
| 其他非流动金融资产 | 10,000,000 | 10,000,000 | - | - |
| 投资性房地产 | 4,480,975.26 | 4,538,155.13 | - | - |
| 固定资产 | 570,144,260.88 | 578,226,954.16 | 81,669,048.03 | 75,475,547.77 |
| 在建工程 | 42,395,834.8 | 25,298,009.26 | 491,215,369.56 | 9,259,955.22 |
| 使用权资产 | 23,101,872.69 | 21,133,392.08 | 24,831,666.14 | 15,607,228.37 |
| 无形资产 | 67,580,042.49 | 66,963,458.19 | 32,448,848.13 | 32,685,844.05 |
| 开发支出 | 11,444,010.61 | 8,513,156.07 | 4,315,597.8 | 1,834,762.02 |
| 长期待摊费用 | 4,007,273.26 | 4,384,267.66 | 4,345,967.83 | 4,270,208.55 |
| 递延所得税资产 | 58,417,284.95 | 56,555,494.35 | 69,527,445.13 | 59,800,211.09 |
| 其他非流动资产 | 59,600 | 632,300 | 1,244,444.44 | 251,324,761.72 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 791,631,154.94 | 776,245,186.9 | 719,598,387.06 | 460,258,518.79 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,801,209,875.26 | 2,890,469,587.02 | 2,816,646,211.15 | 2,561,482,238.89 |
| 流动负债: | | | | |
| 短期借款 | 562,037,777.78 | 409,545,194.19 | 371,000,000 | 200,000,000 |
| 应付票据及应付账款 | 166,269,162.19 | 324,364,029.34 | 312,239,809.84 | 255,275,092.43 |
| 其中：应付票据 | 27,550,000 | 71,500,000 | 61,083,324.74 | - |
| 应付账款 | 138,719,162.19 | 252,864,029.34 | 251,156,485.1 | 255,275,092.43 |
| 合同负债 | 204,416,712.51 | 222,254,276.35 | 245,902,694.04 | 308,724,426.43 |
| 应付职工薪酬 | 17,939,328.88 | 41,721,472.06 | 25,835,064.34 | 24,089,343.11 |
| 应交税费 | 9,584,819.29 | 16,857,001.15 | 24,109,206.19 | 8,361,994.24 |
| 其他应付款合计 | 7,114,652.37 | 12,360,267.3 | 7,397,904.56 | 7,417,566.07 |
| 一年内到期的非流动负债 | 7,813,555.4 | 5,825,252.63 | 11,146,888.06 | 8,743,914.78 |
| 其他流动负债 | 49,294,345.72 | 52,998,196.77 | 54,133,120.38 | 39,339,393.19 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,024,470,354.14 | 1,085,925,689.79 | 1,051,764,687.41 | 851,951,730.25 |
| 非流动负债: | | | | |
| 租赁负债 | 13,157,881.89 | 12,863,354.35 | 10,574,266.66 | 4,334,078.36 |
| 预计负债 | 8,995,084.03 | 9,609,764 | 9,015,098.41 | 8,267,286.78 |
| 递延收益 | 27,964,000.71 | 28,154,502.06 | 9,900,376.12 | 10,079,504.74 |
| 递延所得税负债 | - | 0 | 617,275.09 | 642,015.99 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 50,116,966.63 | 50,627,620.41 | 30,107,016.28 | 23,322,885.87 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,074,587,320.77 | 1,136,553,310.2 | 1,081,871,703.69 | 875,274,616.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 105,600,000 | 105,600,000 | 105,600,000 | 105,600,000 |
| 资本公积 | 1,286,565,718.09 | 1,281,787,769.49 | 1,309,901,958.01 | 1,298,025,299.36 |
| 盈余公积 | 34,694,027.6 | 34,694,027.6 | 27,758,581 | 27,758,581 |
| 未分配利润 | 299,762,808.8 | 331,834,479.73 | 291,513,968.45 | 254,823,742.41 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,726,622,554.49 | 1,753,916,276.82 | 1,734,774,507.46 | 1,686,207,622.77 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,726,622,554.49 | 1,753,916,276.82 | 1,734,774,507.46 | 1,686,207,622.77 |
| 负债和股东权益合计 | 2,801,209,875.26 | 2,890,469,587.02 | 2,816,646,211.15 | 2,561,482,238.89 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-30 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |